Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated - Billheimer, JT; Dicker, IB; Wynn, R; Bradley, JD; Cromley, DA; Godonis, HE; Grimminger, LC; He, B; Kieras, CJ; Pedicord, DL; Spitz, SM; Thomas, BE; Zolotarjova, NI; Gorko, MA; Hollis, GF; Daly, RN; Stern, AM; Seiffert, D (Blood, 2002)